Jounce Therapeutics, Inc.
(NASDAQ GS: JNCE)
Rigrodsky Law, P.A. is investigating Jounce Therapeutics, Inc. (“Jounce”) regarding possible breaches of fiduciary duties and other violations of law related to Jounce’s agreement to merge with Redx Pharma Plc.